Skip to main content
. Author manuscript; available in PMC: 2024 Nov 17.
Published in final edited form as: Prev Oncol Epidemiol. 2023 Nov 17;1(1):1–9. doi: 10.1080/28322134.2023.2265563

Table 1: Contributing groups to the HDFCCC strategic plan.

Groups 1 and 2 were extant groups; Group 3 was convened for the purposes of Phase 1 of the planning process and then disbanded.

(1) CCSG Programs (2a) Site Committees (2b) Developing Initiatives (3) Thematic Task Forces
Breast Oncology
Cancer Control
Cancer Genetics
Cancer Immunology
Experimental Therapeutics
Hematopoietic Malignancies
Neurologic Oncology
Pediatric Malignancies
Prostate Cancer
Tobacco Control
Breast
Cutaneous/Melanoma
Cancer Control
Cancer Immunotherapy
Experimental Therapeutics
Gastrointestinal (GI)
Genitourinary (GU)
Gynecology
Hematopoietic
Metabolic Imaging and Radioisotope Therapy
Neurologic
Oral, Head, and Neck
Pediatric
Radiation Oncology
Symptom Management
Thoracic
Geriatric Oncology
Global Cancer
Integrative Oncology
Survivorship and Symptom Science
Theranostics
Understanding the Mechanisms of Cancer (etiology)
Preventing Cancer
Detecting and Diagnosing Cancer
Developing Cancer Cures
Delivering Heath Care to All
Developing Tools to Study Cancer